Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1 G93A mouse model of amyotrophic lateral sclerosis

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Gifondorwa, David J ^a,b   Jimenz Moreno, Ramon ^a   Hayes, Crystal D ^a,c   Rouhani, Hesam ^a   Robinson, Mac B ^a   Strupe, Jane L ^a   Caress, James ^a   Milligan, Carol ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866181145     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/170426     Document Type: Article

References (65)

1. Gould T. W., Buss R. R., Vinsant S., Prevette D., Sun W., Knudson C. M., Milligan C. E., Oppenheim R. W., Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. Journal of Neuroscience 2006 26 34 8774 8786 2-s2.0-33748261830 10.1523/JNEUROSCI.2315-06. 2006 (Pubitemid 44319413)
2. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P., Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. Journal of Neuroscience 2000 20 7 2534 2542 2-s2.0-0034175513 (Pubitemid 30220340)
3. Fischer L. R., Culver D. G., Tennant P., Davis A. A., Wang M., Castellano-Sanchez A., Khan J., Polak M. A., Glass J. D., Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology 2004 185 2 232 240 2-s2.0-0345742771 10.1016/j.expneurol.2003.10.004 (Pubitemid 38084849)
4. Schaefer A. M., Sanes J. R., Lichtman J. W., A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. Journal of Comparative Neurology 2005 490 3 209 219 2-s2.0-23744445580 10.1002/cne.20620 (Pubitemid 41140989)
5. Saxena S., Cabuy E., Caroni P., A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nature Neuroscience 2009 12 5 627 636 2-s2.0-67349164383 10.1038/nn.2297
6. Amendola J., Verrier B., Roubertoux P., Durand J., Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience 2004 20 10 2822 2826 2-s2.0-9644257278 10.1111/j.1460-9568.2004.03745.x (Pubitemid 39573798)
7. Mourelatos Z., Gonatas N. K., Stieber A., Gurney M. E., Dal Canto M. C., The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proceedings of the National Academy of Sciences of the United States of America 1996 93 11 5472 5477 2-s2.0-0029890685 10.1073/pnas.93.11.5472 (Pubitemid 26159474)
8. Stieber A., Chen Y., Wei S., Mourelatos Z., Gonatas J., Okamoto K., Gonatas N. K., The fragmented neuronal Golgi apparatus in amyotrophic lateral sclerosis includes the trans-Golgi-network functional implications. Acta Neuropathologica 1998 95 3 245 253 2-s2.0-0031887308 10.1007/s004010050794 (Pubitemid 28120669)
9. Bendotti C., Calvaresi N., Chiveri L., Prelle A., Moggio M., Braga M., Silani V., De Biasi S., Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. Journal of the Neurological Sciences 2001 191 1-2 25 33 2-s2.0-0035886428 10.1016/S0022-510X(01)00627-X (Pubitemid 33035892)
10. Gonatas N. K., Stieber A., Gonatas J. O., Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. Journal of the Neurological Sciences 2006 246 1-2 21 30 2-s2.0-33744531110 10.1016/j.jns.2006. 01.019 (Pubitemid 43815336)
11. Ilieva H., Polymenidou M., Cleveland D. W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. Journal of Cell Biology 2009 187 6 761 772 2-s2.0-74049164709 10.1083/jcb.200908164
12. Ritossa F., A new puffing pattern induced by temperature shock and DNP in drosophila. Experientia 1962 18 12 571 573 2-s2.0-34250561475 10.1007/BF02172188
13. Stetler R. A., Gan Y., Zhang W., Liou A. K., Gao Y., Cao G., Chen J., Heat shock proteins: cellular and molecular mechanisms in the central nervous system. Progress in Neurobiology 2010 92 2 184 211 2-s2.0-77955199612 10.1016/j.pneurobio.2010.05.002
14. Voisine C., Pedersen J. S., Morimoto R. I., Chaperone networks: tipping the balance in protein folding diseases. Neurobiology of Disease 2010 40 1 12 20 2-s2.0-77955844171 10.1016/j.nbd.2010.05.007
15. Gifondorwa D. J., Robinson M. B., Hayes C. D., Taylor A. R., Prevette D. M., Oppenheim R. W., Caress J., Milligan C. E., Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience 2007 27 48 13173 13180 2-s2.0-36849005504 10.1523/JNEUROSCI.4057-07.2007 (Pubitemid 350220502)
16. Truett G. E., Heeger P., Mynatt R. L., Truett A. A., Walker J. A., Warman M. L., Preparation of PCR-quality mouse genomic dna with hot sodium hydroxide and tris (HotSHOT). BioTechniques 2000 29 1 52 54 2-s2.0-0033922371 (Pubitemid 30439416)
17. Heiman-Patterson T. D., Deitch J. S., Blankenhorn E. P., Erwin K. L., Perreault M. J., Alexander B. K., Byers N., Toman I., Alexander G. M., Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. Journal of the Neurological Sciences 2005 236 1-2 1 7 2-s2.0-24044471670 10.1016/j.jns.2005.02.006 (Pubitemid 41218685)
18. Brown D., Lydon J., McLaughlin M., Stuart-Tilley A., Tyszkowski R., Alper S., Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS). Histochemistry and Cell Biology 1996 105 4 261 267 2-s2.0-0029881544 10.1007/BF01463929 (Pubitemid 26113171)
19. Maeda M., Ohba N., Nakagomi S., Suzuki Y., Kiryu-Seo S., Namikawa K., Kondoh W., Tanaka A., Kiyama H., Vesicular acetylcholine transporter can be a morphological marker for the reinnervation to muscle of regenerating motor axons. Neuroscience Research 2004 48 3 305 314 2-s2.0-1242338818 10.1016/j.neures.2003.11.008 (Pubitemid 38220948)
20. Buchkovich N. J., Maguire T. G., Yu Y., Paton A. W., Paton J. C., Alwine J. C., Human cytomegalovirus specifically controls the levels of the endoplasmic reticulum chaperone BiP/GRP78, which is required for virion assembly. Journal of Virology 2008 82 1 31 39 2-s2.0-37349040367 10.1128/JVI.01881-07 (Pubitemid 350309120)
21. Kieran D., Kalmar B., Dick J. R. T., Riddoch-Contreras J., Burnstock G., Greensmith L., Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nature Medicine 2004 10 4 402 405 2-s2.0-1942486792 10.1038/nm1021 (Pubitemid 38508519)
22. Pun S., Sigrist M., Santos A. F., Ruegg M. A., Sanes J. R., Jessell T. M., Arber S., Caroni P., An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron 2002 34 3 357 370 2-s2.0-0037171788 10.1016/S0896-6273(02)00670-0 (Pubitemid 34465495)
23. Pun S., Santos A. F., Saxena S., Xu L., Caroni P., Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nature Neuroscience 2006 9 3 408 419 2-s2.0-33344462702 10.1038/nn1653 (Pubitemid 43290971)
24. Raff M. C., Whitmore A. V., Finn J. T., Neuroscience: axonal self-destruction and neurodegeneration. Science 2002 296 5569 868 871 2-s2.0-0037012844 10.1126/science.1068613 (Pubitemid 34464884)
25. Medana I. M., Esiri M. M., Axonal damage: a key predictor of outcome in human CNS diseases. Brain 2003 126 3 515 530 2-s2.0-0037370914 10.1093/brain/awg061 (Pubitemid 36240854)
26. Palop J. J., Chin J., Mucke L., A network dysfunction perspective on neurodegenerative diseases. Nature 2006 443 7113 768 773 2-s2.0-33750339228 10.1038/nature05289 (Pubitemid 44622680)
27. Gould T. W., Oppenheim R. W., Synaptic dysfunction in disease and following injury in the developing and adult nervous system: caveats in the choice of therapeutic intervention. Neuroscience and Biobehavioral Reviews 2007 31 8 1073 1087 2-s2.0-36448939830 10.1016/j.neubiorev.2007.04.015 (Pubitemid 350161896)
28. Hall E. D., Oostveen J. A., Gurney M. E., Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. GLIA 1998 23 3 249 256 (Pubitemid 28259722)
29. Robinson M. B., Tidwell J. L., Gould T., Taylor A. R., Newbern J. M., Graves J., Tytell M., Milligan C. E., Extracellular heat shock protein 70: a critical component for motoneuron survival. Journal of Neuroscience 2005 25 42 9735 9745 2-s2.0-27144463441 10.1523/JNEUROSCI.1912-05.2005 (Pubitemid 41510913)
30. McGeer P. L., McGeer E. G., Inflammatory processes in amyotrophic lateral sclerosis. Muscle and Nerve 2002 26 4 459 470 2-s2.0-0036787810 10.1002/mus.10191
31. Sargsyan S. A., Monk P. N., Shaw P. J., Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. GLIA 2005 51 4 241 253 2-s2.0-25444522220 10.1002/glia.20210 (Pubitemid 41532100)
32. Magnus T., Beck M., Giess R., Puls I., Naumann M., Toyka K. V., Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle and Nerve 2002 25 5 709 714 2-s2.0-0036234975 10.1002/mus.10090 (Pubitemid 34462611)
33. Gordon P. H., Cheng B., Katz I. B., Mitsumoto H., Rowland L. P., Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 2009 72 22 1948 1952 2-s2.0-67650076729 10.1212/WNL. 0b013e3181a8269b
34. Daube J. R., Electrophysiologic studies in the diagnosis and prognosis of motor neuron diseases. Neurologic Clinics 1985 3 3 473 493 2-s2.0-0022249456 (Pubitemid 16022546)
35. Dadon-Nachum M., Melamed E., Offen D., The dying-back phenomenon of motor neurons in ALS. Journal of Molecular Neuroscience 2011 43 3 470 477 2-s2.0-79955824241 10.1007/s12031-010-9467-1
36. Dupuis L., Loeffler J. P., Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Current Opinion in Pharmacology 2009 9 3 341 346 2-s2.0-65949094823 10.1016/j.coph.2009.03.007
37. Gordon T., Hegedus J., Tam S. L., Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurological Research 2004 26 2 174 185 2-s2.0-1842607229 10.1179/016164104225013806 (Pubitemid 38419101)
38. Gordon T., Ly V., Hegedus J., Tyreman N., Early detection of denervated muscle fibers in hindlimb muscles after sciatic nerve transection in wild type mice and in the G93A mouse model of amyotrophic lateral sclerosis. Neurological Research 2009 31 1 28 42 2-s2.0-60849094474 10.1179/174313208X332977
39. Hegedus J., Putman C. T., Gordon T., Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease 2007 28 2 154 164 2-s2.0-35349025311 10.1016/j.nbd.2007.07.003 (Pubitemid 47615455)
40. Hegedus J., Putman C. T., Tyreman N., Gordon T., Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. Journal of Physiology 2008 586 14 3337 3351 2-s2.0-48949120504 10.1113/jphysiol.2007.149286 (Pubitemid 352003870)
41. Hayworth C. R., Gonzalez-Lima F., Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6. SOD1G93A ALS mouse model. Neuroscience 2009 164 3 975 985 2-s2.0-70350543562 10.1016/j.neuroscience.2009. 08.031
42. Kafkafi N., Yekutieli D., Yarowsky P., Elmer G. I., Data mining in a behavioral test detects early symptoms in a model of amyotrophic lateral sclerosis. Behavioral Neuroscience 2008 122 4 777 787 2-s2.0-50849099195 10.1037/0735-7044.122.4.777
43. Feeney S. J., McKelvie P. A., Austin L., Bernadette Jean-Francois M. J., Kapsa R., Tombs S. M., Byrne E., Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle and Nerve 2001 24 11 1510 1519 2-s2.0-0034773568 10.1002/mus.1176 (Pubitemid 32995587)
44. Guo H., Lai L., Butchbach M. E. R., Stockinger M. P., Shan X., Bishop G. A., Lin C. L. G., Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Human Molecular Genetics 2003 12 19 2519 2532 2-s2.0-0141618315 10.1093/hmg/ddg267 (Pubitemid 37220416)
45. Henkel J. S., Beers D. R., Zhao W., Appel S. H., Microglia in ALS: the good, the bad, and the resting. Journal of Neuroimmune Pharmacology 2009 4 4 389 398 2-s2.0-70449525135 10.1007/s11481-009-9171-5
46. Levine J. B., Kong J., Nadler M., Xu Z., Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). GLIA 1999 28 3 215 224 2-s2.0-0033485920
47. Neusch C., Bähr M., Schneider-Gold C., Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle and Nerve 2007 35 6 712 724 2-s2.0-34249670157 10.1002/mus.20768 (Pubitemid 46835112)
48. Sargsyan S. A., Blackburn D. J., Barber S. C., Monk P. N., Shaw P. J., Mutant SOD1G93A microglia have an inflammatory phenotype and elevated production of MCP-1. NeuroReport 2009 20 16 1450 1455 2-s2.0-74049122793 10.1097/WNR.0b013e328331e8fa
49. Yang W. W., Sidman R. L., Taksir T. V., Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse. Experimental Neurology 2010 227 287 295
50. Papadimitriou D., Le Verche V., Jacquier A., Ikiz B., Przedborski S., Re D. B., Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiology of Disease 2010 37 3 493 502 2-s2.0-75949107667 10.1016/j.nbd.2009.10.005
51. Edgar J. M., Nave K. A., The role of CNS glia in preserving axon function. Current Opinion in Neurobiology 2009 19 5 498 504 2-s2.0-70450207779 10.1016/j.conb.2009.08.003
52. Kriz J., Nguyen M. D., Julien J. P., Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease 2002 10 3 268 278 2-s2.0-0036406903 10.1006/nbdi.2002.0487 (Pubitemid 35217580)
53. Kriz J., Gowing G., Julien J. P., Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Annals of Neurology 2003 53 4 429 436 2-s2.0-0037381851 10.1002/ana.10500 (Pubitemid 36373254)
54. Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W., Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport 2002 13 8 1067 1070 2-s2.0-0037067009 (Pubitemid 34587742)
55. Zhu S., Stavrovskaya I. G., Drozda M., Kim B. Y. S., Ona V., Li M., Sarang S., Liu A. S., Hartley D. M., Wu D. C., Guilans S., Ferrante R. J., Przedborski S., Kristal B. S., Friedlander R. M., Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002 417 6884 74 78 2-s2.0-0037007645 10.1038/417074a (Pubitemid 34498818)
56. Keller A. F., Gravel M., Kriz J., Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Experimental Neurology 2011 228 1 69 79 2-s2.0-79851513221 10.1016/j.expneurol.2010.12.010
57. Chamberlain L. H., Burgoyne R. D., Cysteine string protein functions directly in regulated exocytosis. Molecular Biology of the Cell 1998 9 8 2259 2267 2-s2.0-0031878093 (Pubitemid 28373638)
58. Chamberlain L. H., Burgoyne R. D., Cysteine-string protein: the chaperone at the synapse. Journal of Neurochemistry 2000 74 5 1781 1789 2-s2.0-0034051803 10.1046/j.1471-4159.2000.0741781.x (Pubitemid 30217632)
59. Ying Z., Wang H., Fan H., Zhu X., Zhou J., Fei E., Wang G., Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Human Molecular Genetics 2009 18 22 4268 4281 2-s2.0-70350701842 10.1093/hmg/ddp380
60. Vijayalakshmi K., Alladi P. A., Ghosh S., Prasanna V. K., Sagar B. C., Nalini A., Sathyaprabha T. N., Raju T. R., Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiology of Disease 2011 41 3 695 705 2-s2.0-79151483641 10.1016/j.nbd.2010.12.005
61. Locke M., Noble E. G., Atkinson B. G., Inducible isoform of HSP70 is constitutively expressed in a muscle fiber type specific pattern. American Journal of Physiology 1991 261 5 C774 C779 2-s2.0-0026319184
62. Locke M., Atkinson B. G., Tanguay R. M., Noble E. G., Shifts in type I fiber proportion in rat hindlimb muscle are accompanied by changes in HSP72 content. American Journal of Physiology 1994 266 5 C1240 C1246 2-s2.0-0028008086
63. Hoshino T., Murao N., Namba T., Takehara M., Adachi H., Katsuno M., Sobue G., Matsushima T., Suzuki T., Mizushima T., Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. Journal of Neuroscience 2011 31 14 5225 5234 2-s2.0-79955415881 10.1523/JNEUROSCI.5478-10.2011
64. Liu J., Shinobu L. A., Ward C. M., Young D., Cleveland D. W., Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis. Journal of Neurochemistry 2005 93 4 875 882 2-s2.0-18844444198 10.1111/j.1471-4159.2005.03054.x (Pubitemid 40695746)
65. Park K. H. J., Vincent I., Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta 2008 1782 7-8 462 468 2-s2.0-49649114155 10.1016/j.bbadis.2008.04.001